Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-27

FDA Approved: EUTHYROX — Supplemental Application (Provell Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for EUTHYROX (levothyroxine sodium) from Provell Pharmaceuticals, LLC, updating an existing NDA for thyroid hormone …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EUTHYROX (levothyroxine sodium)

Snippet

SUPPL AP for EUTHYROX (LEVOTHYROXINE SODIUM)